T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Lam Research
LRCX
$408B
| $83.5M | 0.02% |
9,936,950
-44,890
| -0.4% | -$361K |
|
627
Chesapeake Utilities
CPK
$3.25B
| $83.3M | 0.02% |
1,258,872
-9,400
| -0.7% | -$565K |
|
628
Safety Insurance
SAFT
$1.52B
| $82.8M | 0.02% |
1,345,085
+127,680
| +10% | +$7.48M |
|
629
Matthews International
MATW
$725M
| $82.3M | 0.02% |
1,479,692
-4,578
| -0.3% | -$241K |
|
|
TMH
630
DELISTED
Team Health Holdings Inc
TMH
| $82.3M | 0.02% |
2,023,770
-3,260
| -0.2% | -$142K |
|
|
RICE
631
DELISTED
Rice Energy Inc.
RICE
| $81.8M | 0.02% |
3,711,632
+3,677,137
| +10,660% | +$68.8M |
|
632
Norfolk Southern
NSC
$75.3B
| $81.6M | 0.02% |
958,284
+407,584
| +74% | +$34.6M |
|
633
TD Synnex
SNX
$20.4B
| $81.3M | 0.02% |
1,714,144
+1,780
| +0.1% | +$78.1K |
|
|
EIGI
634
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $80.8M | 0.02% |
8,991,642
-3,218,542
| -26% | -$31M |
|
635
Flotek Industries
FTK
$1.35B
| $80.8M | 0.02% |
1,020,096
-9,669
| -0.9% | -$618K |
|
|
AVX
636
DELISTED
AVX Corporation
AVX
| $80.4M | 0.02% |
5,922,180
+348,900
| +6% | +$4.6M |
|
637
Target
TGT
$69.9B
| $79.9M | 0.02% |
1,144,878
-27,908
| -2% | -$2.08M |
|
|
TDAY
638
USA Today Co
TDAY
$1.01B
| $79.8M | 0.02% |
4,418,163
-42,580
| -1% | -$702K |
|
|
OAK
639
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| $79.6M | 0.02% |
1,778,400
+2,500
| +0.1% | +$116K |
|
640
Ally Financial
ALLY
$13.5B
| $78.7M | 0.02% |
4,608,834
+385,727
| +9% | +$6.66M |
|
641
American Public Education
APEI
$826M
| $78.6M | 0.02% |
2,796,960
+85,470
| +3% | +$2.12M |
|
|
CA
642
DELISTED
CA, Inc.
CA
| $78.3M | 0.02% |
2,384,082
-18,700,325
| -89% | -$585M |
|
|
ADPT
643
DELISTED
Adeptus Health Inc
ADPT
| $78.2M | 0.02% |
1,514,578
-767,097
| -34% | -$46M |
|
644
Ultragenyx Pharmaceutical
RARE
$2.65B
| $77.9M | 0.02% |
1,591,977
+242,340
| +18% | +$15.7M |
|
|
ALOG
645
DELISTED
Analogic Corp
ALOG
| $77.8M | 0.02% |
979,557
-4,300
| -0.4% | -$347K |
|
646
Worthington Enterprises
WOR
$2.78B
| $77.4M | 0.02% |
2,967,412
-204,047
| -6% | -$4.71M |
|
|
INVX
647
Innovex International
INVX
$2.13B
| $76.8M | 0.02% |
1,314,142
-210,207
| -14% | -$12.7M |
|
648
Encompass Health
EHC
$12.3B
| $76.7M | 0.02% |
2,482,351
-300,352
| -11% | -$9.4M |
|
649
Grupo Aval
AVAL
$6.35B
| $76.5M | 0.02% |
9,500,710
-42,000
| -0.4% | -$327K |
|
|
IDTI
650
DELISTED
Integrated Device Technology I
IDTI
| $76.4M | 0.02% |
3,795,738
+740,028
| +24% | +$15.7M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.